Investor mix
7 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Private equity | 1 | 14% |
| Accelerator & incubator | 1 | 14% |
Company developing ALK-5 kinase inhibitors for treating solid tumors and multiple myeloma
7 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Private equity | 1 | 14% |
| Accelerator & incubator | 1 | 14% |